By Frank Prenesti
Date: Tuesday 11 Oct 2022
(Sharecast News) - Shares in healthcare company PureTech fell on Tuesday as the company said it and US-based Nektar Therapeutics had ended merger talks only four days after they announced a potential tie up.
By Michele Maatouk
Date: Friday 07 Oct 2022
(Sharecast News) - PureTech Health said on Friday that it has exchanged indicative, non-binding proposals with US biopharmaceutical company Nektar Therapeutics regarding a possible combination.
By Michele Maatouk
Date: Friday 07 Oct 2022
(Sharecast News) - PureTech Health said on Friday that it has exchanged indicative, non-binding proposals with US biopharmaceutical company Nektar Therapeutics regarding a possible combination.
No recent information was found.
| Currency | US Dollars |
| Share Price | $ 64.88 |
| Change Today | $ -0.13 |
| % Change | -0.20 % |
| 52 Week High | $105.78 |
| 52 Week Low | $8.39 |
| Volume | 5 |
| Shares Issued | 180.09m |
| Market Cap | $11,684m |
| RiskGrade | 333 |
| Strong Buy | 4 |
| Buy | 3 |
| Neutral | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 8 |

| Time | Volume / Share Price |
| 16:00 | 110,317 @ $64.88 |
| 15:59 | 100 @ $64.85 |
| 15:59 | 100 @ $64.85 |
| 15:59 | 100 @ $64.86 |
| 15:59 | 100 @ $64.88 |
You are here: research